Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Global & Regional Health Technology Assessment
|
May 28, 2024
Claudio Jommi, Federico Pantellini, Giovanni Giuliani, et al.
Global & Regional Health Technology Assessment
|
June 21, 2024
Patrizia Popoli, Giovanni Giuliani, Arturo Cavaliere, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 24, 2010
Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy
Giovanni Giuliani, Francesco Grossi, Filippo de Marinis, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
September 13, 2012
Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy
Bjoern Schwander, Simona Ravera, Giovanni Giuliani, et al.
Journal of Medical Economics
|
February 9, 2012
Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy
Alexander Diamantopoulos, Maurizio Benucci, Stefano Capri, et al.
Health Economics Review
|
September 23, 2018
Leveraging EUnetHTA's conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer's point of view
Giovanni Giuliani, Frederic Chassagnol, David Traub, et al.
HIV Clinical Trials
|
June 29, 2005
Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in Italy
John Hornberger, Jesse Green, Neil Wintfeld, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
January 25, 2024
The hidden burden of Pediatric urology in Sub-Saharan Africa: an analysis of hospital admission data from three East African Health Centres
Alessandro Calisti, Diaaeldinn Yaseen Salman, Kibreab Belay, et al.
Pharmacoeconomics
|
February 21, 2004
Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C
Sean D Sullivan, Antonio Craxi, Alfredo Alberti, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
June 27, 2025
Unique challenges in managing pediatric colorectal diseases in under-resourced areas: context-aware adaptive responses from short-term surgical outreach visits
Alessandro Calisti, Kibreab Belay, Giovanni Giuliani, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Global & Regional Health Technology Assessment
|
May 28, 2024
Claudio Jommi, Federico Pantellini, Giovanni Giuliani, et al.
Global & Regional Health Technology Assessment
|
June 21, 2024
Patrizia Popoli, Giovanni Giuliani, Arturo Cavaliere, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 24, 2010
Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy
Giovanni Giuliani, Francesco Grossi, Filippo de Marinis, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
September 13, 2012
Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy
Bjoern Schwander, Simona Ravera, Giovanni Giuliani, et al.
Journal of Medical Economics
|
February 9, 2012
Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy
Alexander Diamantopoulos, Maurizio Benucci, Stefano Capri, et al.
Health Economics Review
|
September 23, 2018
Leveraging EUnetHTA's conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer's point of view
Giovanni Giuliani, Frederic Chassagnol, David Traub, et al.
HIV Clinical Trials
|
June 29, 2005
Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in Italy
John Hornberger, Jesse Green, Neil Wintfeld, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
January 25, 2024
The hidden burden of Pediatric urology in Sub-Saharan Africa: an analysis of hospital admission data from three East African Health Centres
Alessandro Calisti, Diaaeldinn Yaseen Salman, Kibreab Belay, et al.
Pharmacoeconomics
|
February 21, 2004
Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C
Sean D Sullivan, Antonio Craxi, Alfredo Alberti, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
June 27, 2025
Unique challenges in managing pediatric colorectal diseases in under-resourced areas: context-aware adaptive responses from short-term surgical outreach visits
Alessandro Calisti, Kibreab Belay, Giovanni Giuliani, et al.
Page
of 2